Skip to main content

Advertisement

SpringerLink
Log in

Oligoclonal reconstitution masquerading as myeloma relapse

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Chim CS (2010) Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients. J Transl Med 8:124

    Article  PubMed  CAS  Google Scholar 

  2. Chim CS, Lie AK, Chan EY, Leung YY, Cheung SC, Chan SY, Liang R, Kwong YL (2010) A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma. Ann Hematol 89(10):1019–1027

    Article  PubMed  CAS  Google Scholar 

  3. Fernández de Larrea C, Tovar N, Cibeira MT, Aróstegui JI, Rosiñol L, Elena M, Filella X, Yagüe J, Bladé J (2011) Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents. Haematologica 96(1):171–173

    Article  PubMed  Google Scholar 

  4. Mark T, Jayabalan D, Coleman M, Pearse RN, Wang YL, Lent R, Christos PJ, Lee JW, Agrawal YP, Matthew S, Ely S, Mazumdar M, Cesarman E, Leonard JP, Furman RR, Chen-Kiang S, Niesvizky R (2008) Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma. Br J Haematol 143(5):654–660

    Article  PubMed  Google Scholar 

  5. Zent CS, Wilson CS, Tricot G, Jagannath S, Siegel D, Desikan KR, Munshi N, Bracy D, Barlogie B, Butch AW (1998) Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood 91(9):3518–3523

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. University Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China

    C. S. Chim

  2. University Department of Pathology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China

    E. Y. T. Chan

Authors
  1. C. S. Chim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Y. T. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. S. Chim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chim, C.S., Chan, E.Y.T. Oligoclonal reconstitution masquerading as myeloma relapse. Ann Hematol 92, 847–848 (2013). https://doi.org/10.1007/s00277-012-1624-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1624-x

Keywords

Search

Navigation